Wegovy maker warns price cuts 'painful' for firm as shares plunge
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
